Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology

SIMPLE SUMMARY: A characteristic across several cancer types is a homologous recombination deficiency (HRD). HRD is associated with a better response to several anticancer therapies. Adequate assessment of HRD can therefore improve the outcome of such therapies. However, current methods to assess HR...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wiel, Alexander M. A., Schuitmaker, Lesley, Cong, Ying, Theys, Jan, Van Hoeck, Arne, Vens, Conchita, Lambin, Philippe, Yaromina, Ala, Dubois, Ludwig J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454578/
https://www.ncbi.nlm.nih.gov/pubmed/36077694
http://dx.doi.org/10.3390/cancers14174157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454578/
https://www.ncbi.nlm.nih.gov/pubmed/36077694
http://dx.doi.org/10.3390/cancers14174157

Ejemplares similares